PALO ALTO, Calif.--(BUSINESS WIRE)--CardioDx, a pioneer in the field of cardiovascular genomic diagnostics, today announced that data related to Corus® CAD, the company’s blood-based gene expression test for ruling out obstructive coronary artery disease in stable symptomatic patients, will be presented at the American Heart Association Scientific Sessions 2011 conference taking place November 12-16 in Orlando, Fla.
